Mesotherapy with dutasteride in the treatment of androgenetic alopecia
International Journal of Trichology · 2017 · 9 (3) · 143
DOI: 10.4103/ijt.ijt_73_16 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Trichology, 2017. Verfasst von David Saceda-Corralo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ramón Y Cajal Hospital, Madrid, Spain. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
International Journal of Trichology / Volume 9 / Issue 3 / July September 2017 143 producing cells.[1] The hair cycle may be affected in different ways in alopecia areata. Inflammation targeting the hair follicle can cause hair loss by production of dystrophic anagen hairs, truncated rapid cycling of short anagen, and telogen hairs or induce prolonged telogen.[4] In our patient, inflammation might have targeted follicular melanocytes as well as perturbed the hair cycle resulting in the short hairs.
Autor:innen und Institutionen
- Department of Dermatology, Ramón Y Cajal Hospital, Madrid, Spain.
- Trichology Unit, Dermatology Clinic Grupo Pedro Jaén, Madrid, Spain.
Zitieren
APA
Saceda-Corralo, D., Rodrigues-Barata, A. R., Vañó-Galván, S., & Jaén-Olasolo, P. (2017). Mesotherapy with dutasteride in the treatment of androgenetic alopecia. International Journal of Trichology, 9(3), 143. https://doi.org/10.4103/ijt.ijt_73_16
Vancouver
Saceda-Corralo D, Rodrigues-Barata AR, Vañó-Galván S, Jaén-Olasolo P. Mesotherapy with dutasteride in the treatment of androgenetic alopecia. International Journal of Trichology. 2017;9(3):143. doi:10.4103/ijt.ijt_73_16
BibTeX
@article{SacedaCorralo2017,
author = {Saceda-Corralo, David and Rodrigues-Barata, Ana Rita and Vañó-Galván, Sergio and Jaén-Olasolo, Pedro},
title = {Mesotherapy with dutasteride in the treatment of androgenetic alopecia},
journal = {International Journal of Trichology},
year = {2017},
volume = {9},
number = {3},
pages = {143},
doi = {10.4103/ijt.ijt_73_16}
}
EUVIMED